Cargando…

Improved synthesis of SV2A targeting radiotracer [(11)C]UCB-J

INTRODUCTION: [(11)C]UCB-J is a tracer developed for PET (positron emission tomography) that has high affinity towards synaptic vesicle glycoprotein 2A (SV2A), a protein believed to participate in the regulation of neurotransmitter release in neurons and endocrine cells. The localisation of SV2A in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rokka, Johanna, Schlein, Eva, Eriksson, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884603/
https://www.ncbi.nlm.nih.gov/pubmed/31784919
http://dx.doi.org/10.1186/s41181-019-0080-5
Descripción
Sumario:INTRODUCTION: [(11)C]UCB-J is a tracer developed for PET (positron emission tomography) that has high affinity towards synaptic vesicle glycoprotein 2A (SV2A), a protein believed to participate in the regulation of neurotransmitter release in neurons and endocrine cells. The localisation of SV2A in the synaptic terminals makes it a viable target for in vivo imaging of synaptic density in the brain. Several SV2A targeting compounds have been evaluated as PET tracers, including [(11)C]UCB-J, with the aim to facilitate studies of synaptic density in neurological diseases. The original two-step synthesis method failed in our hands to produce sufficient amounts of [(11)C]UCB-J, but served as an excellent starting point for further optimizations towards a high yielding and simplified one-step method. [(11)C]Methyl iodide was trapped in a clear THF-water solution containing the trifluoroborate substituted precursor, potassium carbonate and palladium complex. The resulting reaction mixture was heated at 70 °C for 4 min to produce [(11)C]UCB-J. RESULTS: After semi-preparative HPLC purification and reformulation in 10% ethanol/phosphate buffered saline, the product was obtained in 39 ± 5% radiochemical yield based on [(11)C]methyl iodide, corresponding to 1.8 ± 0.5 GBq at EOS. The radiochemical purity was > 99% and the molar activity was 390 ± 180 GBq/μmol at EOS. The product solution contained < 2 ppb palladium. CONCLUSIONS: A robust and high yielding production method has been developed for [(11)C]UCB-J, suitable for both preclinical and clinical PET applications.